BioNTech SE may be able to produce 3 billion doses of the Covid-19 vaccine with its partner Pfizer Inc. next year. The companies’ vaccine has shown a high ability in lab experiments to neutralize strains first detected in Brazil, the U.K. and South Africa. New York state lowered its vaccine eligibility age to 60 from 65.
BioNTech SE may be able to produce 3 billion doses of the Covid-19 vaccine with its partner Pfizer Inc. next year. The companies’ vaccine has shown a high ability in lab experiments to neutralize strains first detected in Brazil, the U.K. and South Africa. New York state lowered its vaccine eligibility age to 60 from 65.
BioNTech SE may be able to produce 3 billion doses of the Covid-19 vaccine with its partner Pfizer Inc. next year. The companies’ vaccine has shown a high ability in lab experiments to neutralize strains first detected in Brazil, the U.K. and South Africa. New York state lowered its vaccine eligibility age to 60 from 65.
BioNTech SE may be able to produce 3 billion doses of the Covid-19 vaccine with its partner Pfizer Inc. next year. The companies’ vaccine has shown a high ability in lab experiments to neutralize strains first detected in Brazil, the U.K. and South Africa. New York state lowered its vaccine eligibility age to 60 from 65.